215 related articles for article (PubMed ID: 27055051)
1. The pharmacodynamics of antiplatelet compounds in thrombosis treatment.
Jayakumar T; Yang CH; Geraldine P; Yen TL; Sheu JR
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):615-32. PubMed ID: 27055051
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet options for secondary prevention in acute coronary syndromes.
Silvain J; Cayla G; O'Connor SA; Collet JP; Montalescot G
Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1403-15. PubMed ID: 22059790
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel withdrawal: is there a "rebound" phenomenon?
Sambu N; Warner T; Curzen N
Thromb Haemost; 2011 Feb; 105(2):211-20. PubMed ID: 21103667
[TBL] [Abstract][Full Text] [Related]
4. Facts and controversies of aspirin and clopidogrel therapy.
Faxon DP; Freedman JE
Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
[TBL] [Abstract][Full Text] [Related]
5. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
Bernlochner I; Byrne RA; Kastrati A; Sibbing D
Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
[TBL] [Abstract][Full Text] [Related]
6. Prasugrel hydrochloride for the treatment of acute coronary syndrome patients.
Gunarathne A; Hussain S; Gershlick AH
Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1215-1226. PubMed ID: 27701930
[TBL] [Abstract][Full Text] [Related]
7. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
[TBL] [Abstract][Full Text] [Related]
8. [Antiplatelet drugs].
Nishikawa M
Nihon Rinsho; 2014 Jul; 72(7):1248-53. PubMed ID: 25163316
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.
Gao W; Zhang Q; Ge H; Guo Y; Zhou Z
Angiology; 2013 Oct; 64(7):554-8. PubMed ID: 23359782
[TBL] [Abstract][Full Text] [Related]
10. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit?
Collet JP; Montalescot G
Int J Cardiol; 2009 Mar; 133(1):8-17. PubMed ID: 19187982
[TBL] [Abstract][Full Text] [Related]
11. Current antiplatelet therapies: benefits and limitations.
Angiolillo DJ; Guzman LA; Bass TA
Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
[TBL] [Abstract][Full Text] [Related]
12. Long-term combination therapy with aspirin and clopidogrel.
Kumana CR; Cheung G; Lauder IJ; Cheung BM
J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):223-5. PubMed ID: 15678241
[TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.
Capranzano P; Capodanno D
Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):307-17. PubMed ID: 23469911
[TBL] [Abstract][Full Text] [Related]
14. Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist.
Azmoon S; Angiolillo DJ
Catheter Cardiovasc Interv; 2013 Feb; 81(2):232-42. PubMed ID: 22581463
[TBL] [Abstract][Full Text] [Related]
15. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
[TBL] [Abstract][Full Text] [Related]
16. Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor.
Marczewski MM; Postula M; Kosior D
Vasc Health Risk Manag; 2010 Jun; 6():419-29. PubMed ID: 20539844
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel: the data, the experience, and the controversies.
Sadanandan S; Singh IM
Am J Cardiovasc Drugs; 2012 Dec; 12(6):361-74. PubMed ID: 23057989
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes.
Monitillo F; Iacoviello M; Caldarola P; Valle R; Chiatto M; Aspromonte N
Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):977-93. PubMed ID: 25882759
[TBL] [Abstract][Full Text] [Related]
19. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
20. Prasugrel: Clinical development and therapeutic application.
Guerra DR; Tcheng JE
Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
